Navigation Links
DrugRisks Stryker Recall Update: Company Warns Investors as Patients Alleging Injury Ask to Send Lawsuits to Federal Court
Date:4/3/2013

Chicago, IL (PRWEB) April 03, 2013

The hip implant safety center at DrugRisks.com is announcing new information on the site for patients who received the recalled Stryker Rejuvenate or ABG II hip systems. Stryker Orthopedics has warned investors it may face substantial litigation as patients alleging injury have asked that lawsuits be moved to a central federal court*****.

DrugRisks was designed to improve the safety of patients using popular medical devices and prescription drugs by sharing the latest warnings, recalls, studies and litigation news. Visitors can see if others are experiencing similar side effects and decide whether they need legal advice.

The resource center contains warnings from the British Medical Journal* and FDA** that toxic metal shavings from all-metal hips like the Stryker ABG II and Rejuvenate can cause serious conditions such as metallic poisoning, tissue damage, bone loss and damage to other organs.

DrugRisks has also advised patients of the Stryker hip recall of the Rejuvenate and ABG II modular implants***. The company admitted that some patients have experienced effects like adverse tissue reaction and elevated metallic blood levels, even when no symptoms are present***.

So far, more than 80 patients alleging injury from the recalled devices have filed a Stryker hip lawsuit in a New Jersey multi-district court****. Plaintiffs recently asked the U.S. Judicial Panel on Multidistrict Litigation to consolidate the growing Stryker hip recall lawsuits to a special federal court in the U.S. District Court, District of Minnesota. (In Re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, Case Pending No. 20 (JPML)).

Now, DrugRisks has added information showing Stryker is advising investors that costs associated with legal claims from patients alleging injury related to the recalled hips may amount to between $190 and $390 million*****.

Anyone who received the recalled Stryker Rejuvenate or ABG II hip implant is urged to contact the DrugRisks hip center or speak with a lawyer about their full legal rights to compensation before signing anything from Stryker or Broadspire, or deciding to take action.

Due to the specialized nature of federal medical device injury cases, DrugRisks only recommends lawyers and law firms who have already handled hip implant or Stryker recall lawsuits.

Visit http://www.DrugRisks.com today for more information on the Stryker hip recall, research, side effects and litigation news, or to speak with a lawyer.

*bmj.com/content/344/bmj.e1410
**http://www.fda.gov/Medicaldevices/productsandmedicalprocedures/implantsandprosthetics/metalonmetalhipimplants/ucm241604.htm
***stryker.com/en-us/products/Orthopaedics/modularneckstems/index.htm
****northjersey.com/mahwah/Over_80_lawsuits_on_hip_implants_filed_against_Mahwah-based_Stryker_Orthopaedics_.html?page=all
*****Stryker 2012 Annual Report, Other Information, Legal and Regulatory Matters, Pg. 19; http://catalog.e-digitaleditions.com/i/114936

Read the full story at http://www.prweb.com/releases/stryker-rejuvenate-hip/recall-lawsuit/prweb10594427.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks Center NuvaRing Lawsuit News: Drug Maker May Have Concealed Risks
2. DrugRisks Adds New Pradaxa Study Alert As Lawsuits Increase
3. DrugRisks Adds Update from First Actos Trial of Patient Alleging Bladder Cancer
4. DrugRisk Adds Update on Stryker Hip Recall: Claims Could Cost $190 to 390 Million
5. Hip Safety Center Update: Patients Ask to Send Stryker Hip Lawsuits to Federal Court
6. Ongoing Litigation Over Failed DePuy and Stryker Hip Implants Continue Driving Traffic to Number One Website for Cobalt Chromium Toxicity Information
7. Update: Number of Stryker Rejuvenate Hip Recall Lawsuits Growing in New Jersey Multicounty Litigation, Announces Wright & Schulte LLC
8. Stryker Hip Recall Lawyers at Wright & Schulte LLC Investigating Claims, as Stryker Hip Implant Lawsuits in New Jersey Hit 80
9. Stryker Hip Lawyers at Bernstein Liebhard LLP Comment on Growing Litigation in Wake of Stryker Rejuvenate Recall
10. Stryker Hip Recall: Bernstein Liebhard LLP Notes Scheduling of Initial Conference in New Jersey Litigation
11. d’Oliveira & Associates Issues Webpage With Current Information On Stryker Hip Implant Lawsuits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... TN (PRWEB) , ... February 17, 2017 , ... ... Inc. (ISTS) brings its educational assistance management solution to the exhibit floor for ... Center in Orlando, Fla. , From Feb. 19–23, 2017, more than 40,000 ...
(Date:2/17/2017)... Verdes, CA (PRWEB) , ... February 17, 2017 ... ... emotional flow is Dr. Carol Francis' goals for each and every ... Conference, Dr. Carol Francis will demonstrate five different brainwave tools which help energize ...
(Date:2/17/2017)... ... February 17, 2017 , ... Qualis Health, one of the ... 8th Annual DecisionHealth Platinum Awards in recognition of its innovative healthcare management programs ... across multiple award categories, highlighting four of the organization’s current programs:, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Program will serve ... Health and the U.S. Soccer Foundation announced today that they have awarded nine ... for Success, the Foundation’s soccer mentoring program, teaches kids the fundamentals of soccer ...
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... ... clinical operations executives and focusing on all facets of clinical trial planning and ... management , patient engagement, and more. In addition, attendees stopping by Pharmica’s booth ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... 16, 2017  Aralez Pharmaceuticals Inc. (NASDAQ: ... today announced that executive management will participate in the ... February 22-23, 2017. Adrian Adams , Chief Executive ... 1:35 p.m. local time on Wednesday, February 22, 2017. ... the event may be accessed from the Investors section ...
(Date:2/16/2017)... REDWOOD CITY, Calif. , Feb. 16, 2017 ... ), a specialty pharmaceutical company focused on the ... treatment of moderate-to-severe acute pain, announced that ... executive officer and a member of the company,s ... Mr. Angotti brings over two decades of experience ...
(Date:2/16/2017)... 16, 2017 Research and Markets has announced ... Analysis & Trends - Function, Application, Cancer Type, Technology - Forecast ... ... Market is poised to grow at a CAGR of around 28.6% ... Some of the prominent trends that the ...
Breaking Medicine Technology: